Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Sex hormones and multiple sclerosis: another informative failure.
Population pharmacokinetics of ponesimod and its primary metabolites in healthy and organ-impaired subjects.
European Commission approves Genzyme’s multiple sclerosis treatment Lemtrada™ (alemtuzumab)
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
Effirma, Synthetic Biologics
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Sleep and Cognitive Function in Multiple Sclerosis.
Association between beta-interferon exposure and hospital events in multiple sclerosis.
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.
Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
Microglia in health and disease.
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.

Pages